Compugen (CGEN) Misses Q4 EPS by 9c

Compugen (NASDAQ: CGEN) reported Q4 EPS of ($0.07), $0.09 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $1.47 million versus the consensus estimate of $11.66 million.

For earnings history and earnings-related data on Compugen (CGEN) click here.

You May Also Be Interested In

• Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis
• Voya Financial estimates Q2 alternative investment pre-tax loss of $9M-$19M
• CIGNA (CI) PT Raised to $381 at Bernstein SocGen Group